EUR vs Latvia: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
EUR
91.0%
in 2025
Latvia
99.0%
in 2025
EUR rank
3rd
Latvia rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- EUR
- Latvia
How they compare
Latvia currently reports 99.0% against 91.0% in EUR, a difference of 8.0%.
That makes Latvia's figure about 1.1 times EUR's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Latvia ahead.
EUR ranks 3rd and Latvia ranks 1st of 12 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | EUR | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.3% | 96.4% | 2.1% | Latvia |
| 2010s | 93.5% | 94.6% | 1.1% | Latvia |
| 2020s | 91.7% | 97.0% | 5.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), EUR or Latvia?
- Latvia, at 99.0% against 91.0% in EUR as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between EUR and Latvia?
- 8.0%, with Latvia ahead.
- How many years of comparable data are there for EUR and Latvia?
- 26 years are reported by both, from 2000 to 2025.
- How do EUR and Latvia rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- EUR ranks 3rd and Latvia ranks 1st of 12 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.